Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities:
Net Income (Loss)	$ (6,605,208)	$ (6,354,290)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	27,892	26,915
Amortization of debt discounts and deferred financing costs	103,595	61,381
Operating Lease, Right-of-Use Asset, Periodic Reduction	67,241	108,538
Stock-based compensation	405,025	248,307
Warrants issued to non-employees	335,633	171,326
Issuance of Common Stock for consulting services	100,000
Gain on settled accounts payable		(101,200)
Changes in current assets and liabilities:
Accounts receivable		2,321
Inventory	47,180	(2,220)
Prepaid and other current assets	236,932	385,773
Deferred offering costs	(517,067)	60,432
Accounts payable	(183,186)	37,824
Accrued liabilities	(58,690)	(310,146)
Lease liability, operating lease	(29,532)	(108,538)
Net cash used in operating activities	(6,070,185)	(5,773,577)
Cash flows from investing activities:
Purchase of property and equipment	(64,455)	(18,308)
Acquisition of intellectual property - intangibles	(60,816)
Net cash used in investing activities	(125,271)	(18,308)
Cash flows from financing activities:
Issuance of Common Stock in IPO, net of fees		5,194,740
Issuance of warrants in IPO		17,250
Issuance of Common Stock for exercise of pre-funded warrants		14
Issuance of Common Stock for bridge warrant exercises		1,141,023
Issuance of Common Stock under equity line, net of offering costs		429,325
Issuance of pre-funded warrants for bridge warrant exercises		150,000
Issuance of Common Stock, net of fees	10,300,013
Proceeds from shareholder note, net	334,249
Principal repayments of finance lease obligations	(291,625)	(398,260)
Net cash provided by investing activities	10,342,637	6,534,092
Net change in cash and cash equivalents during the period	4,147,181	742,207
Cash and cash equivalents, beginning of period	1,660,467	918,260
Cash and cash equivalents, end of period	5,807,648	1,660,467
SUPPLEMENTAL DISCLOSURES OF NON-CASH TRANSACTIONS:
Issuance of Common Stock for $1.5M Note conversions		1,500,000
Issuance of Common Stock for Bridge Note and accrued interest conversions		3,618,704
Issuance of Common Stock for Series A and B Preferred Stock conversions		703
Issuance of Common Stock for Series C Preferred conversions		348
Issuance of Series C Preferred Stock for $130K Note conversion		130,000
Issuance of Common Stock for cashless bridge warrant exercises		31
Issuance of Common Stock warrants in payment of payables		171,326
Issuance of Common Stock as consideration for note conversions	1,022,850
Issuance of Common Stock as consideration for acquired intangible assets	1,528,431
Warrants issued as underwriter compensation		39,953
Financed insurance premiums	$ 277,176	445,636
Operating lease assets obtained in exchange for lease obligations		$ 549,227